NEW YORK – Special purpose acquisition company (SPAC) CA Healthcare Acquisition on Wednesday announced a merger agreement with point-of-care diagnostic testing firm LumiraDx.
The merger with CA Healthcare Acquisition would facilitate the listing of London-based LumiraDx on the Nasdaq under the ticker symbol LMDX.